Calamos Advisors »

Amphastar Pharmaceuticals In shares owned by Calamos Advisors

Quarter-by-quarter ownership of Amphastar Pharmaceuticals In shares owned by Calamos Advisors from 13F filings

Historical chart of Calamos Advisors investment in Amphastar Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Amphastar Pharmaceuticals In held by Calamos Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amphastar Pharmaceuticals In by Calamos Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $11M 10M 1.06

More positions owned by Calamos Advisors

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Palo Alto Networks Note 0.375% 6/0 (Principal)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Visa Com Cl A (V)
UnitedHealth (UNH)

View all positions for Calamos Advisors

Top funds holding Amphastar Pharmaceuticals In

Readystate Asset Management
MacKay Shields
Wolverine Asset Management
Wellesley Investment Advisors
Braidwell
Shenkman Capital Management
Calamos Advisors
SSI Investment Management
Gabelli Funds
Wells Fargo & Company
Citigroup
Healthcare Of Ontario Pension Plan Trust Fund
M&G
Invesco
BlackRock

View all funds holding Amphastar Pharmaceuticals In